08/28/2024 3:30 PM | GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:31 PM | Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 3:31 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:26 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:27 PM | Rhythm Pharmaceuticals (Subject) TETRAULT LYNN A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024 3:27 PM | GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024 3:45 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
08/12/2024 3:13 PM | Rhythm Pharmaceuticals (Subject) TETRAULT LYNN A. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024 5:00 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFR14A | |
08/07/2024 5:03 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
08/06/2024 6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/30/2024 4:09 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2024 4:59 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:30 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/16/2024 3:37 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:34 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024 4:00 PM | Garfield Alastair (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/10/2024 4:01 PM | Garfield Alastair (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B7 | |
07/10/2024 3:07 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:39 PM | MCGIRR DAVID W J (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:41 PM | Arbuckle Stuart A (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:30 PM | GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:35 PM | JEAN CHRISTOPHE (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:37 PM | Bedrosian Camille L (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:38 PM | Mathers Edward T (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 3:38 PM | Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:44 PM | MCGIRR DAVID W J (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:47 PM | Rhythm Pharmaceuticals (Issuer) TETRAULT LYNN A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:38 PM | Arbuckle Stuart A (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:39 PM | GOOD JENNIFER L (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:41 PM | Bedrosian Camille L (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:42 PM | JEAN CHRISTOPHE (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 8:43 PM | Mathers Edward T (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2024 4:28 PM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024 4:19 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:43 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 6:10 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 6:31 PM | NEW ENTERPRISE ASSOCIATES 13 LP (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/26/2024 3:13 PM | Rhythm Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024 3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
04/16/2024 7:11 PM | Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2024 6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 7:00 PM | German Christopher Paul (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 5:18 PM | PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/01/2024 4:25 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/22/2024 3:55 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2024 3:21 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 4:51 PM | PERCEPTIVE ADVISORS LLC (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024 3:41 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 7:50 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:52 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:53 PM | Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:54 PM | Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:56 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2024 7:57 PM | Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 3:58 PM | Rhythm Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024 3:44 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024 3:46 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/22/2024 6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/21/2024 6:00 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:00 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:01 PM | Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:01 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:02 PM | German Christopher Paul (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:02 PM | Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 6:03 PM | Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 5:14 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:45 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:46 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:47 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:49 PM | Mazabraud Yann (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 7:50 PM | Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:13 PM | Rhythm Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
02/09/2024 3:19 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024 5:53 PM | Cramer Pamela J. (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:53 PM | Meeker David P (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:54 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:54 PM | Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:55 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 4:34 PM | GOLDMAN SACHS GROUP INC (Filed by) GOLDMAN SACHS GROUP INC (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024 8:46 AM | BlackRock Inc. (Filed by) Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024 8:04 AM | Rhythm Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/04/2024 6:15 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 3:15 PM | Rhythm Pharmaceuticals (Issuer) Smith Hunter C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 3:30 PM | Rhythm Pharmaceuticals (Issuer) Shulman Joseph (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2023 3:22 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023 3:16 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 3:30 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9288&Placement=NativeDisplay&Source=NativeDisplay) Learn these 4 simple steps and protect your savings before it’s too late. |
12/06/2023 3:34 PM | Rhythm Pharmaceuticals (Subject) Smith Hunter C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/24/2023 12:06 PM | Rhythm Pharmaceuticals (Subject) Smith Hunter C (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023 3:14 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2023 3:14 PM | Rhythm Pharmaceuticals (Subject) Shulman Joseph (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 4:44 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 3:30 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 3:14 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023 5:17 PM | Lee Jennifer Kayden (Reporting) Rhythm Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 6:05 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |